CTS-21166 is a blood-brain barrier-permeable and orally active BACE1 inhibitor. CTS-21166 reduces brain Abeta levels. CTS-21166 can be used in the research of Alzheimers disease[1][2].
Molecular Weight:
657.86
CAS Number:
[1226777-95-2]
Formula:
C34H51N5O6S
Target:
Amyloid-beta,Beta-secretase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted